EPHA8 and neoplasm: In univariate analysis, we identified following prognostic markers associated with poor overall survival: higher EphA8 expression (HR, 4.614, 95% CI: 2.598–8.193; P = 0.001), older age at diagnosis (HR, 3.181, 95% CI: 1.848–5.475; P = 0.001), higher FIGO stage (HR, 4.651, 95% CI: 2.496–8.665; P = 0.001), higher tumor grade (HR, 2.026, 95% CI: 1.063–3.863; P = 0.032), positive lymph nodes (HR, 2.084, 95% CI: 1.131–3.843; P = 0.019), and presence of metastases (HR, 4.869, 95% CI: 2.694–8.801; P = 0.001).